MLchartDataset catalogue

Nerlynx

Term · Oncology and biomedicine · MLC-T-ONC-005740

A drug used alone or with capecitabine to treat adults with certain types of HER2-positive breast cancer that have already been treated. It is also being studied in the treatment of other types of cancer. Nerlynx blocks certain proteins, which may help keep cancer cells from growing and may kill them. It is a type of tyrosine kinase inhibitor. Also called neratinib maleate.

Table 1. Record
IdentifierMLC-T-ONC-005740
FieldOncology and biomedicine
Synonymsneratinib maleate
ReferencesNCI Dictionary of Cancer Terms
Record as JSON
{
  "id": "MLC-T-ONC-005740",
  "term": "Nerlynx",
  "field": "Oncology and biomedicine",
  "definition": "A drug used alone or with capecitabine to treat adults with certain types of HER2-positive breast cancer that have already been treated. It is also being studied in the treatment of other types of cancer. Nerlynx blocks certain proteins, which may help keep cancer cells from growing and may kill them. It is a type of tyrosine kinase inhibitor. Also called neratinib maleate.",
  "synonyms": [
    "neratinib maleate"
  ],
  "references": [
    "NCI Dictionary of Cancer Terms"
  ],
  "url": "https://mlchart.com/terminology/oncology/nerlynx/"
}

Record 11,713 of 17,717 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.